SEQUOIA BIOTECH CONSULTING
DEAD

Serial Number

98377908

Owner

Sequoia Consulting Group, LLC

Attorney

Sara M. Bauer

Filing Date

Jan 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SEQUOIA BIOTECH CONSULTING Trademark

Serial Number: 98377908

SEQUOIA BIOTECH CONSULTING is a trademark filed by Sequoia Consulting Group, LLC on January 26, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Sequoia Consulting Group, LLC (2 trademarks)

315 S. Coast Hwy. 101; Suite U58
Encinitas, CA 92024

Entity Type: 16

Trademark Details

Filing Date

January 26, 2024

Registration Date

Not Registered

Published for Opposition

December 10, 2024

Goods & Services

Business advisory, development, and strategic planning services provided to companies in the life sciences industries; providing business program management services to companies in the life sciences industries; providing business consulting services to assist life sciences organizations and affiliates in the fields of business strategy, product development, new technology implementation, mergers and acquisitions, operational and organization effectiveness; business services, namely, formulation of best practices for life science companies; regulatory submission management, namely, assisting others in preparing and filing documents for approval of therapeutics, diagnostics, and medical devices with governmental regulatory bodies; consulting in the field of regulatory compliance and operations, quality compliance and operations, technology, and productivity to life sciences companies with respect to therapeutics, diagnostics and medical devices

Regulatory compliance and risk management consulting in the fields of biotechnology, diagnostics, therapeutics, and medical devices; consulting in the field of regulatory compliance to life sciences companies with respect to therapeutics, diagnostics and medical devices

technical advisory services in the fields of biotechnology, diagnostics, therapeutics, and medical devices; technical consulting services, namely, providing scientific expertise required for technology transfer, method validation, analytical support, chemistry, manufacturing, and controls (CMC), and quality control; technical consulting services, namely, providing engineering expertise required for technology transfer, automation, process engineering, commissioning, qualification, and validation of equipment and facilities, facility management, and equipment maintenance and support; consulting services for biotechnology, diagnostic, therapeutic and medica device companies in designing, planning, and managing of laboratory moves, new facility builds, and commissioning, qualifying, and validating facilities and equipment; providing consulting services to assist life sciences organizations and affiliates in the fields of product development and new technology implementation; consulting in the field of quality compliance and operations and technology to life sciences companies with respect to therapeutics, diagnostics and medical devices; quality management consulting in the fields of biotechnology, diagnostics, therapeutics, and medical devices

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 9, 2025 ETOP
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Jan 25, 2025 MAB5
ABANDONMENT - AFTER PUBLICATION
Jan 25, 2025 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Jan 24, 2025 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 7, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2024 NWOS
NEW APPLICATION ENTERED
Jan 30, 2024 NWAP